Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-23T14:09:01.978Z Has data issue: false hasContentIssue false

[No Title]

Published online by Cambridge University Press:  02 January 2018

M. R. Garland*
Affiliation:
Beaumont Hospital, Dublin 9, Ireland. E-mail: mgarland@ireland.com
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © Royal College of Psychiatrists, 2002 

The study of Strickland et al (Reference Strickland, Deakin and Percival2002) underpins the considerable inconsistency in the literature that addresses the area of peripheral markers in depression.

It has been argued that neuroendocrine challenge tests (such as the prolactin response to dexfenfluramine used by the authors) is not a valid probe of central neuronal function (for discussion see Reference Weiss and CoccaroWeiss & Coccaro, 1997) and this may account for the negative findings of the study. More perplexing is the lack of association between depression and a reliable index of hypothalamic—pituitary—adrenal (HPA) axis activation, late-night salivary cortisol (reviewed by Reference Kirschbaum and HellhammerKirschbaum & Hellhammer, 1994). In both humans and animals various models of acute and chronic stress (e.g. physical trauma, public speaking, caregiver stress in carers of people with Alzheimer's disease) are reliably associated with hyper-cortisolaemia (Reference Kirschbaum and HellhammerKirschbaum & Hellhammer, 1994). If depression is considered to be an extreme form of chronic stress, why is there so little consistency between studies examining cortisol in populations with depression (Reference Haskett, Mann and KupferHaskett, 1993)?

Strickland et al may have serendipitously discovered a crucial, if seemingly trivial, psycho-biological ‘co-factor’ in depression that dramatically distinguishes between cases with or without HPA axis activation: perceived stress (as measured by the Life Events and Difficulties Schedule (LEDS), see Strickland et al; p. 170, Fig. 1c). Equally depressed patients may not be equally ‘stressed’ and this may have biological as well as clinical consequences. The increased cardiac (Reference Carney, Freedland and ShelineCarney et al, 1997) and oncological (Reference Persky, Kempthorne-Rawson and ShekellePersky et al, 1987) morbidity and mortality associated with depression may particularly apply to the depressed—stressed—hypercortisolaemic sub-group. Clearly more research is needed to explore this possibility.

References

Carney, R. M., Freedland, K. E., Sheline, Y. I., et al (1997) Depression and coronary heart disease: a review for cardiologists. Clinical Cardiology 20, 196200.CrossRefGoogle ScholarPubMed
Haskett, R. F. (1993) The HPA axis and depressive disorders. In Biology of Depressive Disorders, Part A: A Systems Perspective (eds Mann, J.J. & Kupfer, D.J.), pp. 171189. New York: Plenum.CrossRefGoogle Scholar
Kirschbaum, C. & Hellhammer, D. H. (1994) Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology, 19, 313333.CrossRefGoogle ScholarPubMed
Persky, V. W., Kempthorne-Rawson, J. & Shekelle, R. B. (1987) Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosomatic Medicine, 49, 435449.CrossRefGoogle ScholarPubMed
Strickland, P. L., Deakin, J. F., Percival, C., et al (2002) Bio-social origins of depression in the community. Interactions between social adversity cortisol and serotonin neurotransmission. British Journal of Psychiatry, 180, 168173.Google Scholar
Weiss, D. & Coccaro, E. F. (1997) Neuroendocrine challenge studies of suicidal behavior. Psychiatric Clinics of North America, 20, 563579.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.